Cfl Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.50 M
- Company Age 43 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 128.83 Cr
- Revenue Growth -19.69%
- Profit Growth -58.48%
- Ebitda 9.67%
- Net Worth 2.43%
- Total Assets 2.24%
About Cfl Pharmaceuticals
Cfl Pharmaceuticals Limited (CPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 30 September 1981 and has a history of 43 years and four months. Its registered office is in Goa, Goa, India.
The Corporate was formerly known as Cosme Farma Laboratories Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company has closed loans amounting to ₹128.83 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Maryann Menezes, Christine Menezes, and Brenda Menezes serve as directors at the Company.
Company Details
-
Location
Goa, Goa, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24246GA1981PLC000465
-
Company No.
000465
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
30 Sep 1981
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Goa
Industry
Who are the key members and board of directors at Cfl Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maryann Menezes
|
Director | 30-Nov-2012 | Current |
|
Christine Menezes
|
Director | 10-Apr-2013 | Current |
|
Brenda Menezes
|
Director | 30-Oct-2013 | Current |
Financial Performance of Cfl Pharmaceuticals.
Cfl Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.69% decrease. The company also saw a substantial fall in profitability, with a 58.48% decrease in profit. The company's net worth moved up by a moderate rise of 2.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cfl Pharmaceuticals?
In 2022, Cfl Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cosme Bio-Tech Private LimitedMaryann Menezes, Christine Menezes and 1 more are mutual person
-
Menezes Pharmaceuticals LimitedMaryann Menezes, Christine Menezes and 1 more are mutual person
-
Frederick Electro Devices Private Limited
Maryann Menezes, Christine Menezes and 1 more are mutual person
-
Menezes Remedies Limited
Maryann Menezes, Christine Menezes and 1 more are mutual person
-
Cosme Stocks And Credits Private Limited
Maryann Menezes, Christine Menezes and 1 more are mutual person
Charges (Loans)
₹0
₹1,288.29 M
Charges Breakdown by Lending Institutions
- Bank Of India : 128.83 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2012 | Bank Of India | ₹10.65 Cr | Satisfied |
| 19 May 2009 | Bank Of India | ₹10.65 Cr | Satisfied |
| 11 Sep 2007 | Bank Of India | ₹10.65 Cr | Satisfied |
| 11 Sep 2007 | Bank Of India | ₹3.00 M | Satisfied |
| 16 Mar 2005 | Bank Of India | ₹2.50 M | Satisfied |
How Many Employees Work at Cfl Pharmaceuticals?
Cfl Pharmaceuticals has a workforce of 12 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cfl Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cfl Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
